Literature DB >> 28810

Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension.

R G Wilcox.   

Abstract

Atenolol was compared with five other beta-blockers and a thiazide diuretic in a randomised cross-over trial of once-daily treatment of essential hypertension. Atenolol was significantly better at reducing resting and exercise blood pressures at 24 hours than any of the other drugs and had a low incidence of side effects. Both timolol and acebutolol had a significant hypotensive effect at 24 hours and a low incidence of side effects, suggesting that further increases in dosage might be effective and well tolerated. Labetalol proved ineffective when given once daily, and the high incidence of side effects, equalled only by pindolol, would probably prohibit further increases in dosage. Bendrofluazide was equal or superior to all the beta-blockers except atenolol at reducing resting blood pressure, and its cheapness still makes it an agent of first choice in mild or moderate essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 28810      PMCID: PMC1609059          DOI: 10.1136/bmj.2.6134.383

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  5 in total

1.  The effect on blood pressure of beta-adrenoceptor blocking drugs administered once daily and their duration of action when therapy is ceased.

Authors:  M Wilson; G Morgan; T Morgan
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

2.  Once-daily dosing with Atenolol in patients with mild or moderate hypertension.

Authors:  A P Douglas-Jones; J M Cruickshank
Journal:  Br Med J       Date:  1976-04-24

3.  Renal circulatory responses to general anaesthesia in the rabbit: studies using radioactive microspheres.

Authors:  D J Warren; J G Ledingham
Journal:  Clin Sci Mol Med       Date:  1975-01

4.  Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.

Authors:  F J Conway; J D Fitzgerald; J McAinsh; D J Rowlands; W T Simpson
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

5.  A comparison of once and twice daily atenolol in hypertension.

Authors:  C M Castleden; J R Dathan; C F George
Journal:  Postgrad Med J       Date:  1977-11       Impact factor: 2.401

  5 in total
  22 in total

1.  Comparative doses of four antihypertensive drugs.

Authors:  D N Griffith; I M James; C Symons
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335

Review 2.  The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs.

Authors:  R P Ames
Journal:  Drugs       Date:  1986-10       Impact factor: 9.546

3.  The effects of acute or chronic ingestion of propranolol or metoprolol on the metabolic and hormonal responses to prolonged, submaximal exercise in hypertensive men.

Authors:  I A Macdonald; T Bennett; A M Brown; R G Wilcox; A M Skene
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

4.  Once-daily metoprolol for hypertension.

Authors:  M J Ward; J M Roland; D C Banks
Journal:  Postgrad Med J       Date:  1981-10       Impact factor: 2.401

5.  Atenolol versus pindolol: side-effects in hypertension.

Authors:  E C Foerster; P Greminger; W Siegenthaler; H Vetter; W Vetter
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Labetalol in essential hypertension.

Authors:  A Breckenridge; M Orme; M J Serlin; M Maciver
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

7.  Comparison between atenolol and nadolol in essential hypertension at rest and on exercise.

Authors:  R G Wilcox; J R Hampton
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

Review 8.  The effects of antihypertensive drugs on serum lipids and lipoproteins, I. Diuretics.

Authors:  R P Ames
Journal:  Drugs       Date:  1986-09       Impact factor: 9.546

9.  Propranolol vs metoprolol vs labetalol: a comparative study in essential hypertension.

Authors:  M M Kubik; J H Coote
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Labetalol in general practice: a review.

Authors:  J A Kane
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.